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Abstract Second malignancies, mostly in the form of
bone sarcomas, are known to occur in hereditary retin-
oblastomas, which usually present with bilateral disease.
Only 2 cases of Ewing’s sarcoma have been reported in the
literature following sporadic unilateral retinoblastoma. A
5-year-old boy presented to our hospital with Ewing’s
sarcoma of the right humerus (proven by biopsy and
immunohistochemistry) following successful treatment of
retinoblastoma of the left eye with enucleation and che-
motherapy 2 years previously. He was treated with 2 cycles
of chemotherapy followed by radiation therapy. At
15 months follow-up, the tumor had reduced in size and the
child had a good functional outcome. The cumulative risk
of second malignancies in retinoblastoma survivors is 32%.
Ninety-eight percent of second malignancies occur in
patients with bilateral retinoblastoma. Germ line mutations
have been considered in sporadic tumors occurring bilat-
erally and multifocal unilateral sporadic tumors. Bone and
soft tissue sarcomas are the most common second malig-
nancies. Radiation therapy increases the risk of developing
a second malignancy in the irradiated ﬁeld. Unilateral
retinoblastomas, which comprise the majority of retinobl-
astomas, are not immune from the development of second
malignancies. Close follow-up of all retinoblastomas—
even in the early period—can improve the outcome by
facilitating the early detection and aggressive treatment of
second malignancies.
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Introduction
Retinoblastoma (RB) is the most common malignant ocular
tumor in the pediatric age group, occurring in 1/15,000 to
1/30,000 live births [16], although it forms a smaller per-
centage of all pediatric malignancies (*5/1,00,000 chil-
dren) [9]. There are two broad subgroups—hereditary
(40%) and nonhereditary (60%) [10]. The hereditary group
present at a younger age, usually have bilateral disease, and
have an underlying germ line mutation of the RB1 gene.
The nonhereditary group present at a later age, and have
unilateral disease as well as an underlying genetic mutation
arising in the somatic cells. More than 90% of these
patients experience long-term survival due to successful
treatment regimens [1]. Both radiation therapy and che-
motherapy with alkylating agents increase the risk of
subsequent development of bone sarcomas in children who
survive childhood cancers [17]. Nonocular second malig-
nant neoplasms have occurred almost exclusively in chil-
dren with bilateral disease, who constitute only 25% of
cases. The most common second malignant neoplasms in
these patients are sarcomas, especially bone sarcomas,
though a wide variety of second tumors have been reported,
such as melanoma, chondrosarcoma, leukemia, neuroblas-
toma, and leiomyosarcoma [7]. Bone and soft tissue sar-
comas are the most common second malignant neoplasms;
osteogenic sarcoma is the single most common second
malignant neoplasm [7].
Previously, six cases of Ewing’s sarcoma in patients
with a prior history of bilateral [1, 6, 8, 16] and two cases
of unilateral [6, 12] retinoblastoma have been reported.
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developed Ewing’s sarcoma of the right humerus 2 years
after enucleation of the left eye, and a review of the per-
tinent literature.
Case report
A 3-year-old male child was brought to the eye center of
our hospital with a yellow reﬂex in the left eye (cat’s eye
reﬂex), and was found to have retinoblastoma of an
advanced stage. He was subsequently fully investigated
and found to have nonmetastatic locally advanced retino-
blastoma. Since there was no vision in the left eye, enu-
cleation was performed as deﬁnitive treatment and a
specimen was sent for histopathological analysis. It showed
degeneration of all layers of the eyeball, with areas of
calciﬁcation, bone formation and chronic inﬂammatory
inﬁltrates. Focally, a tumor with a collection of small round
blue cells with a high nucleo/cytoplasmic ratio and
hyperchromatic nuclei consistent with retinoblastoma was
evident (Fig. 1). The optic nerve resection limit was free of
tumor. The patient was started on a carboplatin, vincristine
and etoposide chemotherapy protocol postoperatively.
At the age of 5 years, the child was brought to the
orthopedic clinic with complaints of painful swelling of the
right arm that had been present for 1 month, which was
gradually increasing in size (Fig. 2). The pain was reported
to increase at night and was relieved partially by analge-
sics. Local examination revealed a 10 9 4 cm fusiform
swelling involving the distal shaft of the humerus cir-
cumferentially. A local rise in temperature and tenderness
was present over the swelling. Terminal ﬂexion of the
elbow was restricted by 30.
Roentgenograms revealed a lamellated pattern of peri-
osteal reaction and a permeative pattern of osteolysis
involving the distal shaft of the humerus with soft-tissue
shadows (Fig. 3). Gadolinium-enhanced MRI of the part
showed a circumferential, moderately enhancing, well-
marginated peridiaphyseal soft-tissue mass involving the
humeral diaphysis from the proximal third to the distal
metaphysis (Fig. 4a, b).
A whole-body bone scan showed no evidence of bony
metastasis. However, contrast-enhanced computed tomog-
raphy (CECT) of the chest showed two pulmonary nodules
in the right lung, suggestive of metastasis. A guided biopsy
of the nodules conﬁrmed the diagnosis of metastasis.
Open biopsy of the tumor was planned as part of the
staging studies. Biopsy revealed small round tumor cells
arranged in sheets, inﬁltrating into the skeletal muscle.
Cells were small with hyperchromatic nuclei, inconspicu-
ous nucleoli and a high nuclear-to-cytoplasmic ratio. No
rosette formation or Azzopardi phenomenon was seen. This
was an indication of a high-grade tumor with a poor
immunologic/host response. Immunohistochemical stain-
ing for cell-surface glycoprotein p30/32
MIC2(CD99) was
positive, and neuron-speciﬁc enolase was negative,
strongly suggesting a diagnosis of Ewing’s sarcoma,
excluding the possibility of metastasis following
Fig. 1 Low-power view showing malignant small blue round blue
tumor cells, a few macrophages with hemosiderin pigmentation, and
occasional rosette formation (stain: hematoxylin and eosin; original
magniﬁcation, 9 20)
Fig. 2 Clinical photograph of the right arm of the child showing
diffuse swelling extending from the proximal third to just above the
elbow
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tumors (Fig. 5a, b, c).
The patient was classiﬁed as being at an advanced stage
of the disease due to the presence of metastasis. Treatment
was directed towards palliating symptoms at the local site
by radiotherapy and aggressive chemotherapy. Since the
patient was already being treated with a standard chemo-
therapy protocol, a modiﬁed chemotherapy regimen with
ifosfamide and etoposide was undertaken. The patient
underwent 2 cycles of chemotherapy with ifosfamide and
etoposide followed by radiotherapy in 2 phases, initially
with 44 Gy and subsequently with 20 Gy. The patient was
followed up regularly for 18 months. By that time, the
swelling decreased in size and was not tender. Complete
elbow range of motion was regained, and the vision in the
right eye was normal.
Discussion
Survivors of retinoblastoma invariably carry a high risk of
developing a second malignant neoplasm, with the cumu-
lative risk being 32% [1]. Ninety-eight percent of the
secondary malignant tumors occur in patients with bilateral
retinoblastoma or in 15% of patients with unilateral RB
with underlying germline mutation. However, unilateral
RBs comprise almost 75% of all retinoblastomas [1]. By
far the most common second malignant neoplasm has been
osteosarcoma [15]. The second most frequent second
malignant neoplasms have been soft-tissue sarcomas [3].
In children previously irradiated for retinoblastoma,
70% of second malignant neoplasms have occurred in the
ﬁeld and 30% outside the ﬁeld of radiation [1]. Abramson
et al. [1] reviewed 2,302 survivors of childhood retinobl-
astomas. 71.3% of neoplasms occurred within the radiation
therapy ﬁeld after an average latent period of 11.4 years,
and 18.8% occurred outside the radiation ﬁeld after an
average latent period of 11.1 years. Osteosarcoma was the
most common second malignant neoplasm, irrespective of
the relation between radiation therapy ﬁeld and location of
the tumor. Roarty et al. [14] evaluated 215 patients for the
cumulative incidence of second neoplasms in patients with
bilateral retinoblastoma using life table methods. Second
tumors developed in 4.4% of the patients during the ﬁrst
10 years of follow-up, 18.3% after 20 years, and 26.1%
after 30 years. In their group of patients, the 30-year
cumulative incidence was 35.1% for the 137 patients who
received radiation therapy, compared with 5.8% of 78
Fig. 3 Roentgenogram of the right humerus showing a diffuse
periosteal reaction with a permeative type of destruction involving
almost the whole of the diaphysis and a huge soft-tissue shadow
surrounding the diaphysis
Fig. 4 a Axial section at the
mid-shaft humerus after
gadolinium-enhanced MRI,
showing circumferential,
moderately enhancing, well-
marginated peridiaphyseal soft-
tissue mass. b Coronal section
of the humerus after
gadolinium-enhanced MRI
showing an intramedullary
altered signal with moderate
enhancement involving almost
the whole of the diaphysis
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123patients who did not receive radiation therapy. There was a
30-year incidence rate of 29.3% for second tumors within
the ﬁeld of irradiation, and 8.1% outside the ﬁeld. These
ﬁndings suggested that carriers of the retinoblastoma gene
have an increased incidence of second tumors and that the
incidence rate is further increased in patients who received
radiation therapy.
Heritable retinoblastoma and osteosarcoma were found
to be associated in some cases with the deletion of the
13q14 locus of the RB-1 gene [5]. A variety of second
malignant neoplasms have been reported in the literature,
including osteosarcoma, ﬁbrosarcoma, skin carcinomas,
malignant melanomas, rhabdomyosarcomas, acute lym-
phoblastic leukemia, and sinonasal carcinoma, but few
reports indicate the frequency of development of Ewing’s
sarcoma after retinoblastoma [6]. Clinically, it is difﬁcult to
differentiate a unilateral retinoblastoma of heritable type
from nonheritable but generally sporadic tumors occurring
bilaterally, and multifocal unilateral sporadic tumors are
considered germ cell mutations [16]. Patients with unilat-
eral, unifocal retinoblastoma and negative family histories
have not been considered to be at increased risk for second
malignant neoplasms. Although, to the best of our knowl-
edge, the current report is the third (after Helton et al. [6]
and Mittal et al. [12]) on Ewing’s sarcoma in unilaterally
affected patients with retinoblastoma, it is not possible to
exclude the presence of a germinal mutation in any of these
cases.
Skeletal scintigrams are not economically feasible to use
for screening purposes to detect second malignant neo-
plasms, despite their capacity for earlier detection [13].
MRI is a very sensitive method of displaying bone lesions
but, in the absence of localizing symptoms, it is not yet a
practical method of routine skeletal imaging.
Children of affected parents have a 50% risk of having
retinoblastoma [4]. The risk of second malignant neo-
plasms in retinoblastoma has been variably estimated to be
between 1.5 and 90% [11, 16]. This increased incidence is
believed to be secondary to the loss of normal tumor
suppression activity of the retinoblastoma gene on chro-
mosome 13. Radiation or chemotherapy or both put these
patients at further risk, though second malignant neoplasms
are also common in patients who have not received these
adjuvant treatments. Patients with the genetic form of ret-
inoblastoma are also at higher risk.
Our patient developed a second malignancy 2 years
after the initial diagnosis of RB, but this period is much
shorter than those described in previous reports (Table 1):
Fig. 5 a Low-power view showing tumor cells inﬁltrating into soft
tissue in a cord-like pattern (stain, hematoxylin and eosin; original
magniﬁcation, 9 20). b High-power view showing malignant blue
round tumor cells with scanty cytoplasm and dispersed chromatin
along with many mitotic ﬁgures showing PAS positivity and
conspicuously absent rosette formation, indicating a poorly differen-
tiated high-grade tumor (stain, hematoxylin and eosin; original
magniﬁcation, 9 40). c Immunohistochemistry showing tumor cells
with Mic-2 positivity but which are negative for neuron-speciﬁc
enolase (stain, immunohistochemical; original magniﬁcation, 9 20)
Table 1 Ewing’s sarcoma as a second malignant neoplasm after retinoblastoma:literature review
Sl. no. Author [reference] Year of
publication
Unilateral/bilateral
retinoblastoma
Latent
period
Age of
presentation
Other remarks
1 Kitchen [8] 1976 Bilateral – – –
2 Kitchen [8] 1976 Bilateral – – –
3 Schifter et al. [16] 1983 Bilateral 9 yrs – –
4 Abrahamson et al. [1] 1984 Bilateral – – RT given
5 Abrahamson et al. [1] 1984 Bilateral – – RT given
6 Helton et al. [6] 1993 Bilateral 12.5 yrs 13.1 yrs Chemoradiotherapy given
7 Helton et al. [6] 1993 Unilateral 18.25 yrs 21 yrs Death due to metastasis
8 Mittal et al. [12] 2008 Unilateral 3 yrs 4 yrs Chemotheray ? surgery ? autologous stem cell
transplantation
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1234.3 years [4], 14.2 years [4], and 18 years (range
10–32 years) [2]. The clinical outcome of children who
develop a second malignancy depends upon the location
and response of the second tumor to treatment, and
aggressive multi-modality therapy is the key [2]. Our
patient who underwent very aggressive treatment, which
included induction chemotherapy, surgery and high-dose
chemotherapy, is surviving and being followed up very
closely.
The present case highlights the fact that patients with
retinoblastoma are at an increased risk of developing a
second malignant neoplasm, the latency of which is highly
variable. It is also worth noting that unilateral retinoblas-
toma, which represents the majority of cases, is not
immune from the development of second malignant neo-
plasms, considering that a germline mutation can never be
ruled out. Ewing’s sarcoma, a tumor which responds
excellently to chemoradiotherapy, should not be missed in
the primary diagnosis of bone sarcomas presenting as
second malignant neoplasms. Close follow-up, early
detection and aggressive treatment of second malignant
neoplasms can improve the outcome.
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